U.S. Physical Therapy, Inc. Logo

U.S. Physical Therapy, Inc.

USPH

(2.5)
Stock Price

90,00 USD

4.22% ROA

3.06% ROE

79.05x PER

Market Cap.

1.168.134.968,00 USD

37.28% DER

2.26% Yield

2.35% NPM

U.S. Physical Therapy, Inc. Stock Analysis

U.S. Physical Therapy, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

U.S. Physical Therapy, Inc. Fundamental Stock Analysis
# Analysis Rating
1 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

2 Dividend

Investors can take comfort in the company's unwavering commitment to dividends, as it has consistently distributed payouts over the past five years, ensuring a reliable income stream.

3 ROE

The stock's ROE falls within an average range (9.7%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (9.06%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 PBV

The stock's PBV ratio (2.38x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 DER

The stock maintains a fair debt to equity ratio (53%), indicating a reasonable balance between the money it owes and the ownership it possesses.

7 Dividend Growth

The company's dividend growth has been consistently strong over the past three years, with annual increases that demonstrate its commitment to rewarding shareholders.

8 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (1.240) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

10 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

11 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

U.S. Physical Therapy, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

U.S. Physical Therapy, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

U.S. Physical Therapy, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

U.S. Physical Therapy, Inc. Revenue
Year Revenue Growth
1991 600.000
1992 2.400.000 75%
1993 8.400.000 71.43%
1994 17.200.000 51.16%
1995 24.900.000 30.92%
1996 32.200.000 22.67%
1997 38.800.000 17.01%
1998 44.000.000 11.82%
1999 49.935.000 11.89%
2000 63.222.000 21.02%
2001 80.948.000 21.9%
2002 94.739.000 14.56%
2003 105.568.000 10.26%
2004 118.308.000 10.77%
2005 132.122.000 10.46%
2006 135.194.000 2.27%
2007 151.686.000 10.87%
2008 187.686.000 19.18%
2009 201.409.000 6.81%
2010 211.233.000 4.65%
2011 237.006.000 10.87%
2012 252.088.000 5.98%
2013 264.058.000 4.53%
2014 305.074.000 13.44%
2015 331.302.000 7.92%
2016 356.546.000 7.08%
2017 414.051.000 13.89%
2018 453.911.000 8.78%
2019 481.969.000 5.82%
2020 422.969.000 -13.95%
2021 495.022.000 14.56%
2022 553.144.000 10.51%
2023 600.028.000 7.81%
2023 604.802.000 0.79%
2024 668.760.000 9.56%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

U.S. Physical Therapy, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1991 0
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

U.S. Physical Therapy, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1991 0
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 4.800.000 100%
1997 4.800.000 0%
1998 5.600.000 14.29%
1999 6.487.000 13.67%
2000 7.607.000 14.72%
2001 9.120.000 16.59%
2002 11.334.000 19.53%
2003 13.967.000 18.85%
2004 16.802.000 16.87%
2005 16.425.000 -2.3%
2006 17.247.000 4.77%
2007 17.326.000 0.46%
2008 23.727.000 26.98%
2009 23.395.000 -1.42%
2010 22.986.000 -1.78%
2011 24.777.000 7.23%
2012 24.782.000 0.02%
2013 25.931.000 4.43%
2014 30.399.000 14.7%
2015 31.067.000 2.15%
2016 32.479.000 4.35%
2017 35.889.000 9.5%
2018 41.349.000 13.2%
2019 45.049.000 8.21%
2020 42.037.000 -7.17%
2021 46.533.000 9.66%
2022 46.111.000 -0.92%
2023 0 0%
2023 51.953.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

U.S. Physical Therapy, Inc. EBITDA
Year EBITDA Growth
1991 -300.000
1992 -1.000.000 70%
1993 -1.300.000 23.08%
1994 -500.000 -160%
1995 3.000.000 116.67%
1996 5.300.000 43.4%
1997 6.700.000 20.9%
1998 7.800.000 14.1%
1999 9.356.000 16.63%
2000 12.715.000 26.42%
2001 19.514.000 34.84%
2002 21.829.000 10.61%
2003 20.588.000 -6.03%
2004 20.553.000 -0.17%
2005 23.795.000 13.62%
2006 23.090.000 -3.05%
2007 25.021.000 7.72%
2008 29.842.000 16.16%
2009 34.332.000 13.08%
2010 39.443.000 12.96%
2011 46.825.000 15.77%
2012 43.096.000 -8.65%
2013 44.339.000 2.8%
2014 52.526.000 15.59%
2015 55.327.000 5.06%
2016 58.405.000 5.27%
2017 64.526.000 9.49%
2018 70.162.000 8.03%
2019 83.080.000 15.55%
2020 76.589.000 -8.48%
2021 88.364.000 13.33%
2022 82.690.000 -6.86%
2023 87.220.000 5.19%
2023 85.251.000 -2.31%
2024 96.508.000 11.66%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

U.S. Physical Therapy, Inc. Gross Profit
Year Gross Profit Growth
1991 100.000
1992 700.000 85.71%
1993 2.200.000 68.18%
1994 4.000.000 45%
1995 7.500.000 46.67%
1996 10.100.000 25.74%
1997 11.500.000 12.17%
1998 13.200.000 12.88%
1999 15.843.000 16.68%
2000 20.322.000 22.04%
2001 26.068.000 22.04%
2002 30.208.000 13.7%
2003 30.964.000 2.44%
2004 33.033.000 6.26%
2005 35.912.000 8.02%
2006 35.843.000 -0.19%
2007 37.361.000 4.06%
2008 47.603.000 21.52%
2009 55.170.000 13.72%
2010 59.417.000 7.15%
2011 64.493.000 7.87%
2012 62.585.000 -3.05%
2013 64.701.000 3.27%
2014 76.167.000 15.05%
2015 78.361.000 2.8%
2016 82.012.000 4.45%
2017 90.617.000 9.5%
2018 101.663.000 10.87%
2019 112.474.000 9.61%
2020 94.450.000 -19.08%
2021 117.182.000 19.4%
2022 112.024.000 -4.6%
2023 111.716.000 -0.28%
2023 111.986.000 0.24%
2024 124.260.000 9.88%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

U.S. Physical Therapy, Inc. Net Profit
Year Net Profit Growth
1991 -200.000
1992 -1.200.000 83.33%
1993 -2.200.000 45.45%
1994 -2.800.000 21.43%
1995 700.000 500%
1996 1.600.000 56.25%
1997 2.400.000 33.33%
1998 1.600.000 -50%
1999 2.394.000 33.17%
2000 3.735.000 35.9%
2001 7.071.000 47.18%
2002 8.488.000 16.69%
2003 7.331.000 -15.78%
2004 6.678.000 -9.78%
2005 8.791.000 24.04%
2006 6.296.000 -39.63%
2007 8.892.000 29.19%
2008 10.004.000 11.12%
2009 11.767.000 14.98%
2010 15.645.000 24.79%
2011 20.974.000 25.41%
2012 17.933.000 -16.96%
2013 12.723.000 -40.95%
2014 19.767.000 35.64%
2015 22.279.000 11.28%
2016 20.551.000 -8.41%
2017 22.256.000 7.66%
2018 10.103.000 -120.29%
2019 57.259.000 82.36%
2020 52.491.000 -9.08%
2021 57.924.000 9.38%
2022 43.407.000 -33.44%
2023 28.048.000 -54.76%
2023 14.674.000 -91.14%
2024 27.536.000 46.71%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

U.S. Physical Therapy, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1991 0
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 1 0%
2002 1 0%
2003 1 0%
2004 1 0%
2005 1 0%
2006 1 0%
2007 1 0%
2008 1 0%
2009 1 100%
2010 1 0%
2011 2 0%
2012 2 0%
2013 1 0%
2014 2 0%
2015 2 0%
2016 2 0%
2017 2 0%
2018 1 0%
2019 4 100%
2020 4 0%
2021 4 0%
2022 3 -33.33%
2023 2 -50%
2023 1 -100%
2024 2 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

U.S. Physical Therapy, Inc. Free Cashflow
Year Free Cashflow Growth
1991 -400.000
1992 -2.900.000 86.21%
1993 -5.800.000 50%
1994 -6.700.000 13.43%
1995 900.000 844.44%
1996 2.700.000 66.67%
1997 2.000.000 -35%
1998 2.600.000 23.08%
1999 2.953.000 11.95%
2000 6.034.000 51.06%
2001 11.828.000 48.99%
2002 13.959.000 15.27%
2003 12.399.000 -12.58%
2004 12.914.000 3.99%
2005 7.404.000 -74.42%
2006 13.817.000 46.41%
2007 15.013.000 7.97%
2008 25.873.000 41.97%
2009 27.068.000 4.41%
2010 26.848.000 -0.82%
2011 29.433.000 8.78%
2012 35.015.000 15.94%
2013 40.158.000 12.81%
2014 40.027.000 -0.33%
2015 34.980.000 -14.43%
2016 42.790.000 18.25%
2017 49.431.000 13.43%
2018 65.812.000 24.89%
2019 52.259.000 -25.93%
2020 92.356.000 43.42%
2021 68.205.000 -35.41%
2022 50.289.000 -35.63%
2023 73.514.000 31.59%
2023 13.813.000 -432.21%
2024 26.821.000 48.5%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

U.S. Physical Therapy, Inc. Operating Cashflow
Year Operating Cashflow Growth
1991 -200.000
1992 -1.700.000 88.24%
1993 -3.400.000 50%
1994 -2.800.000 -21.43%
1995 2.400.000 216.67%
1996 4.700.000 48.94%
1997 3.800.000 -23.68%
1998 5.000.000 24%
1999 5.050.000 0.99%
2000 8.861.000 43.01%
2001 15.172.000 41.6%
2002 19.524.000 22.29%
2003 17.532.000 -11.36%
2004 17.884.000 1.97%
2005 18.252.000 2.02%
2006 18.472.000 1.19%
2007 19.047.000 3.02%
2008 30.172.000 36.87%
2009 30.944.000 2.49%
2010 30.521.000 -1.39%
2011 32.655.000 6.53%
2012 39.249.000 16.8%
2013 44.795.000 12.38%
2014 45.194.000 0.88%
2015 41.243.000 -9.58%
2016 51.050.000 19.21%
2017 56.526.000 9.69%
2018 73.005.000 22.57%
2019 62.448.000 -16.91%
2020 99.995.000 37.55%
2021 76.406.000 -30.87%
2022 58.537.000 -30.53%
2023 82.808.000 29.31%
2023 16.364.000 -406.04%
2024 29.157.000 43.88%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

U.S. Physical Therapy, Inc. Capital Expenditure
Year Capital Expenditure Growth
1991 200.000
1992 1.200.000 83.33%
1993 2.400.000 50%
1994 3.900.000 38.46%
1995 1.500.000 -160%
1996 2.000.000 25%
1997 1.800.000 -11.11%
1998 2.400.000 25%
1999 2.097.000 -14.45%
2000 2.827.000 25.82%
2001 3.344.000 15.46%
2002 5.565.000 39.91%
2003 5.133.000 -8.42%
2004 4.970.000 -3.28%
2005 10.848.000 54.19%
2006 4.655.000 -133.04%
2007 4.034.000 -15.39%
2008 4.299.000 6.16%
2009 3.876.000 -10.91%
2010 3.673.000 -5.53%
2011 3.222.000 -14%
2012 4.234.000 23.9%
2013 4.637.000 8.69%
2014 5.167.000 10.26%
2015 6.263.000 17.5%
2016 8.260.000 24.18%
2017 7.095.000 -16.42%
2018 7.193.000 1.36%
2019 10.189.000 29.4%
2020 7.639.000 -33.38%
2021 8.201.000 6.85%
2022 8.248.000 0.57%
2023 9.294.000 11.25%
2023 2.551.000 -264.33%
2024 2.336.000 -9.2%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

U.S. Physical Therapy, Inc. Equity
Year Equity Growth
1991 2.200.000
1992 8.200.000 73.17%
1993 6.100.000 -34.43%
1994 4.700.000 -29.79%
1995 5.900.000 20.34%
1996 8.600.000 31.4%
1997 11.600.000 25.86%
1998 13.300.000 12.78%
1999 13.103.000 -1.5%
2000 12.421.000 -5.49%
2001 29.915.000 58.48%
2002 35.561.000 15.88%
2003 46.625.000 23.73%
2004 53.490.000 12.83%
2005 56.499.000 5.33%
2006 59.388.000 4.86%
2007 75.055.000 20.87%
2008 87.822.000 14.54%
2009 92.225.000 4.77%
2010 116.383.000 20.76%
2011 121.580.000 4.27%
2012 134.659.000 9.71%
2013 155.121.000 13.19%
2014 174.590.000 11.15%
2015 201.953.000 13.55%
2016 257.878.000 21.69%
2017 308.969.000 16.54%
2018 350.818.000 11.93%
2019 379.451.000 7.55%
2020 409.970.000 7.44%
2021 452.443.000 9.39%
2022 484.568.000 6.63%
2023 652.238.000 25.71%
2023 668.205.000 2.39%
2024 669.969.000 0.26%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

U.S. Physical Therapy, Inc. Assets
Year Assets Growth
1991 2.400.000
1992 8.900.000 73.03%
1993 10.300.000 13.59%
1994 14.500.000 28.97%
1995 15.900.000 8.81%
1996 19.500.000 18.46%
1997 22.500.000 13.33%
1998 24.100.000 6.64%
1999 23.346.000 -3.23%
2000 22.970.000 -1.64%
2001 36.184.000 36.52%
2002 41.033.000 11.82%
2003 52.473.000 21.8%
2004 61.608.000 14.83%
2005 66.519.000 7.38%
2006 71.457.000 6.91%
2007 96.252.000 25.76%
2008 118.247.000 18.6%
2009 111.254.000 -6.29%
2010 140.861.000 21.02%
2011 163.252.000 13.72%
2012 171.714.000 4.93%
2013 224.135.000 23.39%
2014 244.551.000 8.35%
2015 279.913.000 12.63%
2016 351.231.000 20.31%
2017 418.982.000 16.17%
2018 443.166.000 5.46%
2019 560.845.000 20.98%
2020 594.361.000 5.64%
2021 749.426.000 20.69%
2022 858.154.000 12.67%
2023 1.028.084.000 16.53%
2023 1.010.186.000 -1.77%
2024 1.023.134.000 1.27%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

U.S. Physical Therapy, Inc. Liabilities
Year Liabilities Growth
1991 200.000
1992 700.000 71.43%
1993 4.200.000 83.33%
1994 9.800.000 57.14%
1995 10.000.000 2%
1996 10.900.000 8.26%
1997 10.900.000 0%
1998 10.800.000 -0.93%
1999 10.243.000 -5.44%
2000 10.549.000 2.9%
2001 6.269.000 -68.27%
2002 5.472.000 -14.57%
2003 5.848.000 6.43%
2004 8.118.000 27.96%
2005 10.020.000 18.98%
2006 12.069.000 16.98%
2007 21.197.000 43.06%
2008 30.425.000 30.33%
2009 19.029.000 -59.89%
2010 24.478.000 22.26%
2011 41.672.000 41.26%
2012 37.055.000 -12.46%
2013 69.014.000 46.31%
2014 69.961.000 1.35%
2015 77.960.000 10.26%
2016 93.353.000 16.49%
2017 110.013.000 15.14%
2018 92.348.000 -19.13%
2019 181.394.000 49.09%
2020 184.391.000 1.63%
2021 296.983.000 37.91%
2022 373.586.000 20.5%
2023 375.846.000 0.6%
2023 341.981.000 -9.9%
2024 353.165.000 3.17%

U.S. Physical Therapy, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
41.64
Net Income per Share
0.98
Price to Earning Ratio
79.05x
Price To Sales Ratio
1.86x
POCF Ratio
15.11
PFCF Ratio
17.09
Price to Book Ratio
2.41
EV to Sales
2.09
EV Over EBITDA
15.45
EV to Operating CashFlow
17
EV to FreeCashFlow
19.23
Earnings Yield
0.01
FreeCashFlow Yield
0.06
Market Cap
1,17 Bil.
Enterprise Value
1,31 Bil.
Graham Number
26.63
Graham NetNet
-12.14

Income Statement Metrics

Net Income per Share
0.98
Income Quality
3.77
ROE
0.03
Return On Assets
0.01
Return On Capital Employed
0.07
Net Income per EBT
0.33
EBT Per Ebit
0.68
Ebit per Revenue
0.11
Effective Tax Rate
0.25

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.19
Operating Profit Margin
0.11
Pretax Profit Margin
0.07
Net Profit Margin
0.02

Dividends

Dividend Yield
0.02
Dividend Yield %
2.26
Payout Ratio
2.22
Dividend Per Share
1.75

Operating Metrics

Operating Cashflow per Share
5.13
Free CashFlow per Share
4.53
Capex to Operating CashFlow
0.12
Capex to Revenue
0.01
Capex to Depreciation
0.54
Return on Invested Capital
0.08
Return on Tangible Assets
0.04
Days Sales Outstanding
44.39
Days Payables Outstanding
2.93
Days of Inventory on Hand
0
Receivables Turnover
8.22
Payables Turnover
124.56
Inventory Turnover
0
Capex per Share
0.59

Balance Sheet

Cash per Share
7,49
Book Value per Share
44,45
Tangible Book Value per Share
-0.19
Shareholders Equity per Share
32.15
Interest Debt per Share
12.52
Debt to Equity
0.37
Debt to Assets
0.18
Net Debt to EBITDA
1.72
Current Ratio
1.88
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,15 Bil.
Invested Capital
899162999
Working Capital
0,09 Bil.
Intangibles to Total Assets
0.66
Average Receivables
0,08 Bil.
Average Payables
0,00 Bil.
Average Inventory
0.5
Debt to Market Cap
0.15

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

U.S. Physical Therapy, Inc. Dividends
Year Dividends Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 100%
2020 0 0%
2021 1 100%
2022 2 0%
2023 2 0%
2024 1 0%

U.S. Physical Therapy, Inc. Profile

About U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

CEO
Mr. Christopher J. Reading
Employee
3.899
Address
1300 West Sam Houston Parkway South
Houston, 77042

U.S. Physical Therapy, Inc. Executives & BODs

U.S. Physical Therapy, Inc. Executives & BODs
# Name Age
1 Mr. Jake Martinez
Senior Vice President of Finance & Accounting
70
2 Mr. Jason Anderson
Vice President of Human Resources
70
3 Ms. Jayne Fleck Pool ATC, PT, SCS
Senior Vice President & Chief Compliance Officer
70
4 Mr. Richard S. Binstein
Executive Vice President, General Counsel & Secretary
70
5 Mr. Jon C. Bates CPA, M.B.A.
Vice President & Corporate Controller
70
6 Mr. Eric Joseph Williams
President & Chief Operating Officer
70
7 Mr. Graham D. Reeve M.B.A., P.T.
Chief Operating Officer - West
70
8 Mr. Chadd Pence
Senior Vice President of Information Systems
70
9 Mr. Christopher J. Reading
Chairman & Chief Executive Officer
70
10 Mr. Carey P. Hendrickson
Chief Financial Officer
70

U.S. Physical Therapy, Inc. Competitors